JPMorgan Starts Eli Lilly (LLY) at Overweight, Added to Analyst Focus List
JPMorgan analyst Chris Schott initiates coverage on Eli Lilly (NYSE: LLY) with a Overweight rating and a price target of $140.00.
- Schoot puts a Overweight recommendation on the equity following a period of Not Rated.
- Adds the name to the Analyst Focus List.
- Says premium valuation is warranted given the company above peer top and bottom-line growth.
Shares of Eli Lilly closed at $123.50 yesterday.